7. Implementing measures (Rule 106)

The following draft implementing measures falling under the regulatory procedure with scrutiny had been forwarded to Parliament:

- Commission Regulation amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for bispyribac, denatonium benzoate, fenoxycarb, flurochloridone, quizalofop-P-ethyl, quizalofop-P-tefuryl, propaquizafop, tebufenozide in or on certain products (D059757/03 - 2019/2674(RPS) - deadline: 28 May 2019)
referred to committee responsible: ENVI

- Commission Regulation amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for aminopyralid, captan, cyazofamid, flutianil, kresoxim-methyl, lambda-cyhalothrin, mandipropamid, pyraclostrobin, spiromesifen, spirotetramat, teflubenzuron and tetraconazole in or on certain products (D060905/02 - 2019/2682(RPS) - deadline: 2 June 2019)
referred to committee responsible: ENVI

- Commission Regulation amending Annexes II and IV to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for aclonifen, Beauveria bassiana strain PPRI 5339, Clonostachys rosea strain J1446, fenpyrazamine, mefentrifluconazole and penconazole in or on certain products (D060911/02 - 2019/2675(RPS) - deadline: 28 May 2019)
referred to committee responsible: ENVI.